SE8903226L - Kemiska foereningar - Google Patents

Kemiska foereningar

Info

Publication number
SE8903226L
SE8903226L SE8903226A SE8903226A SE8903226L SE 8903226 L SE8903226 L SE 8903226L SE 8903226 A SE8903226 A SE 8903226A SE 8903226 A SE8903226 A SE 8903226A SE 8903226 L SE8903226 L SE 8903226L
Authority
SE
Sweden
Prior art keywords
optionally substituted
hydrogen atom
image
halogen atoms
alkyl
Prior art date
Application number
SE8903226A
Other languages
English (en)
Swedish (sv)
Other versions
SE8903226D0 (sv
Inventor
N S Watson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8903226D0 publication Critical patent/SE8903226D0/xx
Publication of SE8903226L publication Critical patent/SE8903226L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8903226A 1988-10-03 1989-10-02 Kemiska foereningar SE8903226L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds

Publications (2)

Publication Number Publication Date
SE8903226D0 SE8903226D0 (sv) 1989-10-02
SE8903226L true SE8903226L (sv) 1990-04-04

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903226A SE8903226L (sv) 1988-10-03 1989-10-02 Kemiska foereningar

Country Status (19)

Country Link
US (2) US5013749A (OSRAM)
JP (1) JPH02188571A (OSRAM)
KR (1) KR900006297A (OSRAM)
AU (1) AU628862B2 (OSRAM)
BE (1) BE1003007A3 (OSRAM)
CH (1) CH680442A5 (OSRAM)
DE (1) DE3932887A1 (OSRAM)
DK (1) DK483689A (OSRAM)
ES (1) ES2019163A6 (OSRAM)
FI (1) FI894648A7 (OSRAM)
FR (1) FR2637183A1 (OSRAM)
GB (1) GB2223224B (OSRAM)
GR (1) GR890100634A (OSRAM)
IT (1) IT1237470B (OSRAM)
LU (1) LU87600A1 (OSRAM)
NL (1) NL8902441A (OSRAM)
NO (1) NO893909L (OSRAM)
PT (1) PT91878B (OSRAM)
SE (1) SE8903226L (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
EP0422895A1 (en) * 1989-10-10 1991-04-17 Glaxo Group Limited Chemical compounds
PL361097A1 (en) * 2000-10-12 2004-09-20 Nissan Chemical Industries, Ltd. Preventives and remedies for complications of diabetes
IL158300A0 (en) * 2001-04-27 2004-05-12 Bristol Myers Squibb Co Bisarylimidazol derivatives and pharmaceutical compositions containing the same
KR20060133013A (ko) * 2004-04-16 2006-12-22 워너-램버트 캄파니 엘엘씨 신규 이미다졸
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
WO2005115397A2 (en) * 2004-04-29 2005-12-08 Pharmix Corporation Compositions and treatments for modulating kinase and/or hmg-coa reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
EP2626069A4 (en) 2010-10-06 2014-03-19 Univ Tokyo Prophylactic and/or therapeutic agent against lymphedema

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
HUT48208A (en) * 1985-10-25 1989-05-29 Sandoz Ag Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
EP0244364A3 (en) * 1986-04-30 1992-04-01 Sandoz Ag Preparation of olefinic compounds
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.

Also Published As

Publication number Publication date
AU4243189A (en) 1990-04-05
PT91878A (pt) 1990-04-30
AU628862B2 (en) 1992-09-24
CH680442A5 (OSRAM) 1992-08-31
KR900006297A (ko) 1990-05-07
DK483689A (da) 1990-04-04
NL8902441A (nl) 1990-05-01
DK483689D0 (da) 1989-10-02
FI894648A0 (fi) 1989-10-02
LU87600A1 (fr) 1990-05-15
FR2637183A1 (fr) 1990-04-06
DE3932887A1 (de) 1990-04-05
IT8948424A0 (it) 1989-10-02
GB2223224B (en) 1992-01-08
NO893909D0 (no) 1989-10-02
FI894648L (fi) 1990-04-04
SE8903226D0 (sv) 1989-10-02
BE1003007A3 (fr) 1991-10-22
IT1237470B (it) 1993-06-07
NO893909L (no) 1990-04-04
US5120848A (en) 1992-06-09
PT91878B (pt) 1995-05-31
JPH02188571A (ja) 1990-07-24
GR890100634A (el) 1990-11-29
FI894648A7 (fi) 1990-04-04
US5013749A (en) 1991-05-07
GB2223224A (en) 1990-04-04
GB8922212D0 (en) 1989-11-15
IT8948424A1 (it) 1991-04-02
ES2019163A6 (es) 1991-06-01

Similar Documents

Publication Publication Date Title
SE8903226D0 (sv) Kemiska foereningar
SE7907121L (sv) Ftalimidinderivat
DK114783D0 (da) Hidtil ukendte forbindelser, fremgangsmader til deres fremstilling samt deres anvendelse som laegemidler
ES8405782A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
AU561450B2 (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
IL57577A (en) 1,2-dihydroquinolin-2-one derivatives,processes for their preparation and pharmaceutical compositions containing the same
NO924783D0 (no) Terapeutiske midler
DK0379412T3 (da) Derivater af 1,8-benzonaphthyridin, fremstilling af disse forbindelser og midler, som indeholder forbindelserne
ZA805499B (en) Substituted oxiranecarboxylic acids, processes for their preparation, their use and medicaments containing them
SE7609460L (sv) 3-alkoxi-benso-1,2,4-triazinderivat med fungicid och baktericid verkan och forfarande for framstellning derav
EP0351255A3 (en) Derivatives of û2-(4-piperidinyl)methyl¨-1,2,3,4-tetrahydroisoquinoline, their preparation and their use in therapy
GR78961B (OSRAM)
DE3167049D1 (de) Diphenylbutyl-1-acylpiperazines
ES469234A1 (es) Procedimiento de preparacion de derivados de piridazinona
NZ236186A (en) Pyrrolidine and piperidine derivatives and pharmaceutical compositions
DK558786A (da) Basisk substituerede pyridinforbindelser, fremstilling deraf, samt laegemidler, indeholdende disse
SE8605458D0 (sv) 4-hydroxycoumarin derivatives
GB1064293A (en) Substituted 2-pyrrylketones
IL67360A0 (en) Alpha-azolylglycols and their use as fungicides
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
SE8006142L (sv) 1,2,4-triazol-3-tioler
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
ATE19629T1 (de) N-substituierte derivate des tetrahydroisophthalimids.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8903226-2

Effective date: 19940501

Format of ref document f/p: F